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November 20111546 Abstractssion (78%), diabetes (47%), hyperlipidemia (50%), coronary artery disease
(25%), congestive heart failure (12%), chronic obstructive pulmonary disease
(8%), hemodialysis dependence (15%) and active tobacco use (27%). Use of
several medications increased after bypass: aspirin (51% to 66%), statins (53% to
62%), beta blockers (37% to 50%). Clopidogrel use was unchanged after bypass
(33%). Mean follow up was 342 days (range 3-1591 days). At two-years,
cumulative graft patency was 67%, limb salvage was 67%, and survival was 81%.
Aspirin usage increased secondary graft patency from 46% to 83% (P  .005)
and 51% to 73% (P  .05), respectively. Usage of clopidogrel or beta-blocker
did not have a statistically significant effect on patency. Statin usage increased
secondary graft patency from 59% to 73% (P .03).
Conclusion: Medications commonly prescribed for atherosclerosis such as
aspirin and statins demonstrated patency benefit in patients undergoing infraingui-
nal bypass in a population with predominantly critical limb ischemia.
Nonlinear Mechanical Behavior of the Common, External, and Inter-
nal Carotid Arteries In Vivo
Alexey V. Kamenskiy, PhD, Yuris A. Dzenis, PhD, Jason N. MacTaggart,
MD, Thomas G. Lynch, MD, Syed A Jaffar Kazmi, MD, Iraklis I. Pipinos,
MD, Engineering Mechanics, University of Nebraska-Lincoln, Lincoln,
Neb
Introduction: The mechanical environment and properties of the
carotid artery play an important role in the formation and progression of
atherosclerosis in the carotid bifurcation. The purpose of this work was to
measure and compare the range and variation of circumferential stress and
tangent elastic moduli in the human common (CCA), external (ECA) and
internal (ICA) carotid arteries over the cardiac cycle in vivo.
Methods:Measurements were performed in the surgically exposed prox-
imal cervical CCA, distal ECA and distal ICAof normotensive patients (n 16)
undergoing carotid endarterectomy. All measurements were completed over
the cardiac cycle in the repaired bifurcation. B-mode Duplex ultrasonography
and semi-automatic segmentation algorithm were used to track changes in the
arterial diameter and wall thickness in response to pressure measured concur-
rently with an angiocatheter placed in theCCA.Thesemeasurements were then
used to calculate the variation of circumferential stresses, tangent elasticmoduli,
and dynamic stiffness of the arterial wall.
Results: The diameter and wall thickness of CCA, ECA and ICA were
found to decrease and dynamic stiffness to increase from proximal CCA to
distal ECA and ICA. The circumferential stress from end-diastole to peak-
systole varied nonlinearly from 257 to 63  23 kPa (CCA), from 22  7
to 57  19 kPa (ECA) and from 28  8 to 67  23 kPa (ICA). Tangent
elastic moduli also varied nonlinearly as follows: from 0.40 0.25 to 1.50
2.05 MPa (CCA), from 0.490.34 to 1.14  0.52 MPa (ECA) and from
0.68 0.31 to 1.51 0.69 MPa (ICA). The dynamic stiffness of CCA and
ECA increased more than 3-fold and the dynamic stiffness of ICA increased
more than 2.5-fold at peak-systole compared to end-diastole.
Conclusions: The in vivo mechanical behavior of CCA, ECA and
ICA was qualitatively similar, but quantitatively different. All three
arteries exhibited nonlinear variations of circumferential stress and tan-
gent elastic moduli within the normal pressure range. The variability in
the properties of CCA, ECA and ICA indicates a need for development of
carotid models that match the in vivo properties of the carotid segments.
The observed nonlinear behavior points to the need for future vascular
mechanical studies to evaluate the mechanical factors of the arterial wall
over the entire cardiac cycle.
Connecting the True Lumen: A Multicenter Experience Evaluating
Chronic Total Occlusion Crossing With the Wildcat Catheter (the
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Institute, Jobst Vascular Institute, Toledo, Ohio
Objectives: Percutaneous techniques for crossing femoropopliteal
chronic total occlusions (CTOs) offer an alternative to bypass surgery in
patients deemed to be at increased risk due to advanced age or comorbidi-
ties. Current research demonstrates increasing success rates in catheters
designed to reconstitute peripherally occluded arteries following failed
guidewire passage. The Wildcat CTO catheter is a novel device with a
rotating distal tip and deployable wedges fashioned for channeling a passage
through arterial occlusions. (Fig). This combination is designed to improve
overall operator device control and create a more reliable true lumen passage
for therapeutic endpoints.
Methods: This study is a prospective, multicenter, non-randomized
trial. Enrolled patients demonstrated a CTO of the femoropopliteal arteries
and were not able to be successfully crossed with initial guidewire tech-
niques. The primary measured efficacy endpoint is guidewire placement into
the true distal lumen after Wildcat passage, as confirmed by angiography.
Secondary safety and efficacy endpoints were assessed within a 30-day
timeframe. Procedural site reporting was independently ratified by board-
certified angiographic reviewers.
b
wResults: A total of 88 patients were enrolled with an average CTO
ength of 174  96mm, 89% (n  78) of which were de novo lesions.
pproximately 55% (n 48) of all lesions were categorized as containing at
east moderate calcification. Greater than 85% (n  75) of vessels were
uperficial femoral arteries. The device was used in 84 of 88 patients.
uccessful CTO crossing was reported in 89.3% (75/84) of cases with 4.8%
4/84) major adverse events or clinically relevant complications (Table 1).
Conclusions: In this multicenter study, the Wildcat CTO Catheter
emonstrated an 89.3% (n75) crossing rate with little associatedmorbidity
n  0). Results surpassed the study design endpoints.
Answers to questions:
1. This new technology addresses a new method of crossing challeng-
ing femoropopliteal CTOs.
2. This can potentially improve interventional outcomes and proce-
dural patency
able. Primary safety and efficacy
verall efficacy 89.3% (75/84)
verall safety 95.2% (80/84)
ajor adverse event 0.0% (0/84)
1. Death
2. Unplanned major amputation
3. Emergent target vessel revascularization
linically significant perforation 4.8% (4/84)
linically significant embolization 0.0% (0/84)
rade C dissection 0.0% (0/84)
esults of Iliac Stenting for Iliac Artery Occlusions
achinder S. Hans, MD, Gul Sachwani, Michael D. Khoury, MD, Mayo
itsuya, Thomas King, Youssef Rizk, Luay Sayed,MD, Vascular Surgery, St
ohn Macomb, Warren, Mich
Objective: The aim of this study was to evaluate the results of iliac
tenting for iliac artery occlusions.
Methods: A retrospective review of 105 consecutive patients with iliac
rtery occlusions treated by percutaneous iliac stenting from 1998 to 2010
as completed from two teaching hospitals. Demographic and risk factor
ata was compiled. Primary and secondary patency was determined by
aplan-Meier analysis.
Results: One hundred and five patients underwent attempted angio-
lasty/stenting of an iliac artery occlusion. 96 iliac artery occlusions were
uccessfully treated (technical success 91%). Indications for the procedure
ere life style-altering claudication in 68 patients (70%), ischemic rest pain
6 (17%) and ischemic ulcer/toe gangrene 12 (13%). Iliac stenting was
erformed for 50 common iliac artery occlusions (TASC B), 36 external iliac
rtery occlusions (TASC C) and 10 combined common and external iliac
rtery occlusions (TASCD). Four patients underwent simultaneous femoral
rtery endarterectomy. Contralateral iliac stenosis was present in 52 patients
nd twenty-seven had infrainguinal arterial occlusive disease. Unilateral
emoral access 50, bilateral femoral 35, brachial artery 2 and combined
Fig.rachial and femoral access was used in 9 patients. Thrombolysis with TPA
as performed prior to iliac stenting (n3). Technical aids for crossing the
